Pictet Asset Management (Switzerland)’s ImmunityBio IBRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | $59.9K | Sell |
21,556
-2,400,344
| -99% | -$6.67M | ﹤0.01% | 1922 |
|
|
2023
Q1 | $4.41M | Buy |
2,421,900
+1,575,780
| +186% | +$2.87M | 0.01% | 799 |
|
|
2022
Q4 | $4.29M | Buy |
846,120
+207,943
| +33% | +$1.05M | 0.01% | 765 |
|
|
2022
Q3 | $3.17M | Buy |
638,177
+197,199
| +45% | +$980K | ﹤0.01% | 826 |
|
|
2022
Q2 | $1.64M | Buy |
440,978
+28,437
| +7% | +$106K | ﹤0.01% | 962 |
|
|
2022
Q1 | $2.31M | Hold |
412,541
| – | – | ﹤0.01% | 942 |
|
|
2021
Q4 | $2.51M | Buy |
412,541
+101,307
| +33% | +$616K | ﹤0.01% | 960 |
|
|
2021
Q3 | $3.03M | Buy |
+311,234
| New | +$3.03M | ﹤0.01% | 924 |
|